Contact Us
Find A Doctor

Geographic Atrophy AMD

Enrollment Status:

Closed to Enrollment

A phase 2, double-masked, randomized, parallel-group study to investigate the safety, tolerability and efficacy of GSK933776 in adult patients with geographic atrophy (GA) due to age-related macular degeneration (AMD).

Inclusion Criteria:

  1. Adult patients >55 years of age inclusive at the time of signing the informed consent.
  2. Evidence of AMD confirmed by the presence of at least 1 druse >125 µm diameter in either eye.
  3. Well-demarcated GA due to AMD of total area 1.9-17 mm2 measured on color fundus photographs and fundus autofluorescence in the study eye.
  4. Best-corrected ETDRS visual acuity score (approximately 20/200 Snellen VA equivalent) in the study eye. If both eyes are eligible for the study, the eye with the better BCVA score is selected as the study eye.



Contact Us

Dr. Richard Rosen, Principal InvestigatorTel: (212) 979-4284

Melissa Rivas, Research CoordinatorTel: (212) 614-8386

Address310 E. 14th StreetNew York, NY 10003

View all locations